Sarolife 12.5mg Tablet is categorized as an antidepressant that falls under the class of medications known as selective serotonin reuptake inhibitors (SSRI). It is commonly prescribed to address conditions such as depression and anxiety-related disorders including obsessive-compulsive disorder and panic disorder.

This medication plays a crucial role in assisting individuals in overcoming depression by enhancing their mood and alleviating feelings of anxiety and tension. It can be consumed either with or without food, and the appropriate dosage and frequency will be determined by your healthcare provider to ensure effective symptom management.

Patients may initially be put on a lower dose of Sarolife 12.5mg Tablet, with gradual adjustments to achieve optimal therapeutic results. It is essential not to alter the dosage or discontinue the medication without consulting your doctor, as abrupt changes can lead to a worsening of your condition or unpleasant withdrawal symptoms like anxiety, restlessness, palpitations, dizziness, or sleep disturbances.

For optimal outcomes, it is advised to take this medicine consistently at the same time daily. Some individuals may be advised to take it in the morning if experiencing difficulty sleeping. Patience is key, as it may take a few weeks before the benefits of the medication become noticeable. If there is a lack of improvement after four weeks, it is important to inform your doctor.

Common side effects associated with Sarolife 12.5mg Tablet may include nausea, fatigue, dry mouth, loss of appetite, increased sweating, dizziness, nervousness, tremors, insomnia, and constipation. Furthermore, sexual side effects such as decreased libido, delayed ejaculation, and erectile dysfunction might occur. Immediate medical attention should be sought if there is a sudden deterioration in mood or any thoughts of self-harm.

Prior to commencing treatment with Sarolife 12.5mg Tablet, it is crucial to inform your doctor of any pre-existing conditions such as epilepsy, diabetes, liver or kidney disorders, heart complications, or glaucoma, as these factors can impact treatment. Pregnant or breastfeeding individuals should consult their healthcare provider before starting this medication. It is also vital to disclose all other medications being taken to ensure safety, particularly other antidepressants and drugs referred to as MAO inhibitors.